View in EDS

Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors.

Saved in:
Bibliographic Details
Title: Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors.
Authors: Corno C; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Russo D; D3-PharmaChemistry, Istituto Italiano di Tecnologia, Genoa 16163, Italy.; (Present address) Structural Biophysics Facility, Istituto Italiano di Tecnologia, Genova 16163, Italy., Pignotti F; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy., De Giorgi F; D3-PharmaChemistry, Istituto Italiano di Tecnologia, Genoa 16163, Italy., Penna I; D3-PharmaChemistry, Istituto Italiano di Tecnologia, Genoa 16163, Italy.; Medicinal Chemistry and Technologies for Drug Discovery and Delivery Facility, Istituto Italiano di Tecnologia, Genoa 16163, Italy., Saccoliti F; D3-PharmaChemistry, Istituto Italiano di Tecnologia, Genoa 16163, Italy.; (Present address) Dipartimento di Scienze della Vita, della Salute e delle Professioni Sanitarie, Università degli studi Link Campus University, Roma 00165, Italy., Costantino M; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Mirra L; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Pettinari P; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Carenini N; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Corna E; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Perta N; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy., Ciniselli CM; Unit of Bioinformatics and Biostatistics, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Pratesi P; Unit of Bioinformatics and Biostatistics, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Scarpelli R; Medicinal Chemistry and Technologies for Drug Discovery and Delivery Facility, Istituto Italiano di Tecnologia, Genoa 16163, Italy., Bertozzi F; D3-PharmaChemistry, Istituto Italiano di Tecnologia, Genoa 16163, Italy.; (Present address) Computational and Chemical Biology, Istituto Italiano di Tecnologia, Genova 16163, Italy., Verderio P; Unit of Bioinformatics and Biostatistics, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Beretta GL; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Di Muccio G; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy., Di Marino D; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy., Bandiera T; D3-PharmaChemistry, Istituto Italiano di Tecnologia, Genoa 16163, Italy., Perego P; Unit of Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2025 Sep 18; Vol. 8, pp. 50. Date of Electronic Publication: 2025 Sep 18 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2578-532X
DOI:10.20517/cdr.2025.88